🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 22 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/06/2023 | 214,80 | 220,57 | 214,62 | 219,79 | +2,32% | 2,77% | 415.900 |
| 28/06/2023 | 215,00 | 215,00 | 212,00 | 214,80 | -0,15% | 1,40% | 205.400 |
| 27/06/2023 | 219,88 | 220,08 | 214,86 | 215,12 | -2,56% | 2,37% | 354.100 |
| 26/06/2023 | 222,46 | 222,54 | 218,44 | 220,78 | -0,71% | 1,84% | 193.900 |
| 23/06/2023 | 225,29 | 225,30 | 222,19 | 222,36 | -1,27% | 1,38% | 327.800 |
| 22/06/2023 | 223,24 | 226,26 | 221,43 | 225,23 | +0,97% | 2,16% | 235.700 |
| 21/06/2023 | 223,40 | 224,02 | 221,38 | 223,07 | -0,15% | 1,18% | 390.000 |
| 20/06/2023 | 228,20 | 228,20 | 222,69 | 223,40 | -2,98% | 2,41% | 547.300 |
| 16/06/2023 | 230,00 | 232,42 | 230,00 | 230,26 | +0,29% | 1,05% | 659.600 |
| 15/06/2023 | 227,56 | 229,85 | 227,00 | 229,59 | +1,46% | 1,25% | 240.700 |
| 14/06/2023 | 228,76 | 230,83 | 225,46 | 226,28 | -1,42% | 2,35% | 305.300 |
| 13/06/2023 | 226,43 | 231,25 | 225,32 | 229,53 | +0,72% | 2,62% | 258.700 |
| 12/06/2023 | 230,00 | 230,00 | 224,35 | 227,90 | -0,26% | 2,46% | 242.600 |
| 09/06/2023 | 226,12 | 229,32 | 224,64 | 228,49 | +0,88% | 2,07% | 272.000 |
| 08/06/2023 | 221,48 | 227,25 | 220,52 | 226,50 | +2,65% | 3,04% | 377.100 |
| 07/06/2023 | 220,25 | 222,30 | 219,00 | 220,66 | +0,19% | 1,50% | 282.700 |
| 06/06/2023 | 220,00 | 220,88 | 217,61 | 220,25 | +0,63% | 1,49% | 312.200 |
| 05/06/2023 | 216,15 | 219,87 | 215,29 | 218,88 | +0,76% | 2,12% | 278.500 |
| 02/06/2023 | 214,52 | 217,68 | 212,99 | 217,22 | +1,75% | 2,19% | 392.100 |
| 01/06/2023 | 210,40 | 214,54 | 207,00 | 213,48 | +1,78% | 3,58% | 484.000 |
| 31/05/2023 | 205,93 | 211,25 | 205,93 | 209,74 | +2,22% | 2,58% | 1.267.800 |
| 30/05/2023 | 206,03 | 208,20 | 204,44 | 205,19 | -1,03% | 1,82% | 338.400 |
| 26/05/2023 | 212,14 | 213,93 | 207,20 | 207,32 | -2,27% | 3,17% | 359.200 |
| 25/05/2023 | 212,15 | 213,89 | 209,94 | 212,14 | -0,91% | 1,86% | 478.900 |
| 24/05/2023 | 216,75 | 217,90 | 213,99 | 214,09 | -0,97% | 1,80% | 202.400 |
| 23/05/2023 | 218,76 | 219,60 | 216,11 | 216,19 | -1,10% | 1,60% | 262.500 |
| 22/05/2023 | 220,37 | 221,86 | 216,92 | 218,59 | -0,44% | 2,24% | 340.400 |
| 19/05/2023 | 218,02 | 220,31 | 217,45 | 219,56 | +1,28% | 1,31% | 315.700 |
| 18/05/2023 | 215,82 | 216,82 | 213,59 | 216,79 | +0,28% | 1,50% | 288.600 |
| 17/05/2023 | 211,67 | 216,65 | 209,36 | 216,19 | +1,95% | 3,44% | 432.000 |